Reckitt Benckiser Group (RB) Given a GBX 9,000 Price Target at Morgan Stanley

Reckitt Benckiser Group (LON:RB) received a GBX 9,000 ($122.05) price objective from analysts at Morgan Stanley in a research note issued to investors on Tuesday. The brokerage currently has a “buy” rating on the stock. Morgan Stanley’s target price would suggest a potential upside of 31.91% from the stock’s current price.

Several other equities analysts have also issued reports on RB. JPMorgan Chase & Co. raised Reckitt Benckiser Group to an “overweight” rating and raised their price objective for the stock from GBX 6,900 ($93.57) to GBX 7,500 ($101.71) in a report on Wednesday, November 22nd. Liberum Capital dropped their price objective on Reckitt Benckiser Group from GBX 8,700 ($117.98) to GBX 8,000 ($108.49) and set a “buy” rating on the stock in a report on Wednesday, October 25th. Royal Bank of Canada set a GBX 5,600 ($75.94) price objective on Reckitt Benckiser Group and gave the stock a “sell” rating in a report on Friday, October 20th. Jefferies Group dropped their price objective on Reckitt Benckiser Group from GBX 8,150 ($110.52) to GBX 7,500 ($101.71) and set a “hold” rating on the stock in a report on Friday, September 15th. Finally, Deutsche Bank reissued a “buy” rating and set a GBX 8,500 ($115.27) price target on shares of Reckitt Benckiser Group in a report on Thursday, October 12th. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and nine have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of GBX 7,664.55 ($103.94).

Shares of Reckitt Benckiser Group (LON RB) opened at GBX 6,823 ($92.53) on Tuesday. The stock has a market capitalization of $47,860.00 and a price-to-earnings ratio of 2,281.94. Reckitt Benckiser Group has a 52 week low of GBX 6,299 ($85.42) and a 52 week high of GBX 8,110.43 ($109.99).

In other Reckitt Benckiser Group news, insider Christopher Sinclair bought 2,800 shares of the business’s stock in a transaction that occurred on Wednesday, November 1st. The stock was acquired at an average cost of GBX 6,597 ($89.46) per share, with a total value of £184,716 ($250,496.34). Also, insider Adrian Nevil Hennah bought 2,285 shares of the business’s stock in a transaction that occurred on Wednesday, November 8th. The shares were acquired at an average cost of GBX 6,567 ($89.06) per share, with a total value of £150,055.95 ($203,493.29).

ILLEGAL ACTIVITY WARNING: This piece of content was published by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/09/reckitt-benckiser-group-rb-given-a-gbx-9000-price-target-at-morgan-stanley.html.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply